The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Larger Will The Bioresorbable Medical Material Market Become By 2030 Compared To 2026?
The scale of the biosimilar testing services market has seen substantial expansion recently. This market is projected to expand from $1.84 billion in 2025 to $2.08 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.0%. The upward trend observed historically can be linked to factors such as the broadening of biosimilar development initiatives, a rise in regulatory clearances for biosimilars, the expansion of biologics production, increased dependence on contract research organization (CRO) testing services, and advancements in analytical testing methodologies.
The biosimilar testing services market size is projected to experience substantial growth in the coming years. It is anticipated to expand to $3.37 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.8%. This projected increase is primarily driven by factors such as the increasing demand for cost-effective biologic alternatives, the global expansion of biosimilar markets, the growing complexity of biologic molecules, a heightened focus on comparability studies, and rising investments in biosimilar R&D. Throughout the forecast period, prominent trends are expected to include an increasing need for comprehensive analytical characterization, the rising adoption of advanced bioanalytical assays, a growing emphasis on regulatory-compliant testing services, the expansion of outsourced support for biosimilar development, and an enhanced focus on method validation and consistency.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12219&type=smp
Which Growth Drivers Are Expected To Support The Bioresorbable Medical Material Market Forward?
The increasing incidence of autoimmune conditions is anticipated to fuel expansion within the biosimilar testing services market. Autoimmune diseases are characterized by the body’s immune system mistakenly attacking its own healthy tissues and cells, leading to inflammation and damage. The rising occurrence of these conditions stems from a growing demand for effective biologic therapies capable of managing chronic symptoms, reducing flare-ups, and enhancing long-term patient results. Biosimilar testing services are crucial for supporting autoimmune disease treatment by guaranteeing that biosimilars are safe, effective, and similar to original biologics, thereby making therapeutic options more affordable and accessible. For example, in February 2024, data from Arthritis Australia, an Australia-based non-profit organization, estimated that 562,378 Australians would be living with RA in 2025, constituting 14% of all arthritis cases that year. By 2040, this figure is forecast to grow by 33% to 748,721 people, representing an increase of 186,343 Australians with RA compared with 2025. Consequently, the rising prevalence of autoimmune diseases is a significant factor driving the growth of the biosimilar testing services market.
Which Segment Groups Define The Bioresorbable Medical Material Market Landscape?
The bioresorbable medical material market covered in this report is segmented –
1) By Type: Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polysaccharides, Polycaprolactone (PCL), Poly Lactic-Co-Glycolic Acid (PLGA)
2) By Application: Drug Delivery, Orthopedics, Other Applications
3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End-Users
Subsegments:
1) By Polylactic Acid (PLA): Low Molecular Weight PLA, High Molecular Weight PLA, PLA Blends
2) By Polyglycolic Acid (PGA): Homopolymer PGA, Copolymer PGA
3) By Polysaccharides: Chitosan, Alginate, Hyaluronic Acid Derivatives
4) By Polycaprolactone (PCL): Standard PCL, PCL Copolymers
5) By Poly Lactic-Co-Glycolic Acid (PLGA): 50:50 PLGA, 75:25 PLGA
What Trends Are Driving Changes In The Bioresorbable Medical Material Market?
Leading companies in the biosimilar testing services market are focusing on expanding their facilities to introduce new technologies or capabilities that improve productivity and competitiveness. Facility expansion refers to the process of enlarging or upgrading existing physical spaces or infrastructure to accommodate increased operational needs or future growth. For instance, in October 2023, Tanvex BioPharma USA Inc., a US-based biotechnology company, introduced Tanvex CDMO, a modern contract development and manufacturing organization situated in San Diego. This organization offers comprehensive biologics development and manufacturing services, including cell line development, process optimization, analytical testing, and regulatory support. This new facility aims to speed up the advancement of biopharmaceutical products from concept to commercial scale, leveraging cutting-edge technologies and experienced teams to deliver innovative and life-changing biologics to patients worldwide.
Which Organizations Are Involved In The Bioresorbable Medical Material Market?
Major companies operating in the bioresorbable medical material market are Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Kureha Corporation, Evonik Industries AG, Stryker Corporation, Toray Industries Inc., Mitsui Chemicals Inc., Arkema S.A., Royal DSM N.V., Zimmer Biomet Holdings Inc., Ashland Global Holdings Inc., Corbion N.V., Zeus Industrial Products Inc., Unitika Ltd., Danimer Scientific, Synbra Technology, KLS Martin Group, Durect Corporation, Putnam Plastics Corporation, Zhejiang Haizheng Biomaterials Co. Ltd., NatureWorks LLC, Foster Corporation, Poly-Med Inc., Futerro S.A., TotalEnergies Corbion B.V.
Access The Complete Bioresorbable Medical Material Market Report:
Which Region Accounts For The Highest Share Of The Bioresorbable Medical Material Market?
North America was the largest region in the bioresorbable medical material market in 2025. Asia-Pacific is expected to be the fastest-growing region in the bioresorbable medical material market report during the forecast period. The regions covered in the bioresorbable medical material market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Bioresorbable Medical Material Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=12219&type=smp
Browse Through More Reports Similar to the Global Bioresorbable Medical Material Market 2026, By The Business Research Company
Medical Engineered Materials Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/medical-engineered-materials-global-market-report
Core Materials Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/core-materials-global-market-report
Biomaterials Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/biomaterials-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model